Silvia Linari
- Hematology top 0.5%
- Genetics top 2%
- Surgery
- Molecular Biology
- Physiology top 10%
- Co-authors
- Giancarlo CastamanMassimo MorfiniMassimo InnocentiDaniela MelchiorreChristian CarulliStefan LethagenAlberto TosettoClaude Négrier
- Topics
- Hemophilia Treatment and Research (47 papers)Platelet Disorders and Treatments (27 papers)Lysosomal Storage Disorders Research (11 papers)
- Cited by
- HematologyGeneticsInternal Medicine
- Journals
- SHILAP Revista de lepidopterologíaBloodJournal of Cellular Physiology
- Partner nations
- ItalyUnited StatesSweden
In The Last Decade
Silvia Linari
70 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 85
- Hematology 1.3k
- Genetics 388
- Surgery 206
- Molecular Biology 205
- Physiology 199
Countries citing papers authored by Silvia Linari
This map shows the geographic impact of Silvia Linari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Linari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Linari more than expected).
Fields of papers citing papers by Silvia Linari
This network shows the impact of papers produced by Silvia Linari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Linari. The network helps show where Silvia Linari may publish in the future.
Co-authorship network of co-authors of Silvia Linari
This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Linari. A scholar is included among the top collaborators of Silvia Linari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Linari. Silvia Linari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 9 | |
| 4 | 10 | |
| 5 | Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence | 1 |
| 6 | 5 | |
| 7 | 2 | |
| 8 | 16 | |
| 9 | 9 | |
| 10 | 26 | |
| 11 | 50 | |
| 12 | 5 | |
| 13 | 4 | |
| 14 | 28 | |
| 15 | 50 | |
| 16 | 98 | |
| 17 | 79 | |
| 18 | 11 | |
| 19 | 49 | |
| 20 | 19 |
About Silvia Linari
Silvia Linari is a scholar working on Hematology, Genetics and Cell Biology, having authored 75 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (47 papers), Platelet Disorders and Treatments (27 papers) and Lysosomal Storage Disorders Research (11 papers). The work is most often cited by research in Hematology (1.3k citations), Genetics (388 citations) and Internal Medicine (68 citations). Silvia Linari has collaborated with scholars based in Italy, United States and Sweden. Frequent co-authors include Giancarlo Castaman, Massimo Morfini, Massimo Innocenti, Daniela Melchiorre, Christian Carulli, Stefan Lethagen, Alberto Tosetto, Claude Négrier, P. L. Turecek and Alok Srivastava. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.